Chronic graft versus host disease of oral mucosa: Review of available therapies

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 101, Issue 2, 2006, Pages 175-183

  Imanguli, Matin M ^a,c   Pavletic, Steven Z ^b   Guadagnini, Jean Pierre ^a   Brahim, Jaime S ^a   Atkinson, Jane C ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

CHRONIC DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MOUTH DISEASE; MOUTH MUCOSA; PATHOLOGY; PUVA; REVIEW;

ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOUTH DISEASES; MOUTH MUCOSA; PHOTOPHERESIS;

EID: 31544453851     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.08.028     Document Type: Review

References (80)

1. X. Thomas, J.M. Boiron, and F. Huguet Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial J Clin Oncol 22 2004 4075 4086
2. M. Laughlin, M. Eapen, and P. Rubinstein Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia N Engl J Med 351 2004 2265 2275
3. S. Slavin, S. Morecki, L. Weiss, and R. Or Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man Critical reviews in oncology/hematology 46 2003 139 163
4. Y. Takahashi, and R.W. Childs Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma Clin Cancer Res 10 2004 6353S 6359S
5. U. Popat, and R. Krance Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective Brit J Haematol 126 2004 637 649
6. D. van Bekkum, and W. Dirk Stem cell transplantation for autoimmune disorders. Preclinical experiments. Baillière's best practice & research Clin Haematol 17 2004 201 222
7. C. Vermylen Hematopoietic stem cell transplantation in sickle cell disease Blood Rev 17 2003 163 166
8. A.S. Michallet, F. Nicolini, and S. Furst Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT) Bone Marrow Transplant 35 6 2005 601 608
9. S.J. Lee New approaches for preventing and treating chronic graft-versus-host disease Blood 105 11 2005 4200 4206
10. M.E. Flowers, P.M. Parker, and L.J. Johnston Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial Blood 100 2 2002 415 419
11. M. Zecca, A. Prete, and R. Rondelli Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome Blood 100 4 2002 1192 1200
12. S.Z. Pavletic, L.M. Smith, and M.R. Bishop Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation Am J Hematol 78 4 2005 265 274
13. M.J. Laughlin, M. Eapen, and P. Rubinstein Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia N Engl J Med 351 22 2004 2265 2275
14. D.B. Miklos, H.T. Kim, and K.H. Miller Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission Blood 105 7 2005 2973 2978
15. V. Ratanatharathorn, L. Ayash, and C. Reynolds Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody Biol Blood Marrow Transplant 9 8 2003 505 511
16. S. Lee, G. Vogelsang, and M.E. Flowers Chronic graft-versus-host disease Biol Blood Marrow Transplant 9 2003 215 233
17. G. Akpek, S.J. Lee, and M.E. Flowers Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study Blood 102 3 2003 802 809
18. D. Gaziev, M.M. Galimberti, G. Lucarelli, and P. Polchi Chronic graft-versus-host disease: is there an alternative to the conventional treatment? Bone Marrow Transplant 25 2000 689 696
19. N. Chao, P.M. Parker, and J.C. Niland Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease Biol Blood Marrow Transplant 2 1996 86 92
20. K. Sullivan, H.M. Shulman, and R. Storb Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression Blood 57 1981 267 276
21. D. Jacobsohn, J. Margolis, J. Doherty, V. Anders, and G.B. Vogelsang Weight loss and malnutrition in patients with chronic graft-versus-host disease Bone Marrow Transplant 29 2002 231 236
22. A. Busca, F. Locatelli, S. Vai, A.M. Dall'Omo, A. Gargiulo, and M. Falda Clinical grading of oral chronic graft-versus-host disease in 104 consecutive adult patients Haematologica 90 4 2005 567 569
23. M. Schubert, K.M. Sullivan, and T.H. Morton Oral manifestations of chronic graft-v-host disease Arch Intern Med 144 1984 1591 1595
24. S. Woo, S.J. Lee, and M.M. Schubert Graft-vs.-host disease Crit Rev Oral Biol Med 8 1997 201 216
25. P. Lenssen, M.E. Sherry, and C.L. Cheney Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation J Am Dietetic Assoc 90 1990 835 842
26. A. Majorana, M.M. Schubert, F. Porta, A.G. Ugazio, and P.L. Sapelli Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management Support Care Cancer 8 2000 353 365
27. A.D. Mayer, J. Dmitrewski, and J.P. Squifflet Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group Transplantation 64 3 1997 436 443
28. M. Guba, C. Graeb, K.W. Jauch, and E.K. Geissler Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation Transplantation 77 12 2004 1777 1782
29. W. Hogan, and R. Storb Use of cyclosporine in hematopoietic cell transplantation Transplant Proc 36 2004 367S 371S
30. K. Sullivan, R.P. Witherspoon, and R. Storb Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease Blood 72 1988 555 561
31. S. Koc, W. Leisenring, and M.E. Flowers Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone Blood 100 2002 48 51
32. G. Akpek, S.M. Lee, V. Anders, and G.B. Vogelsang A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease Biol Blood Marrow Transplant 7 2001 495 502
33. D. Jacobsohn, and G.B. Vogelsang Novel pharmacotherapeutic approaches to prevention and treatment of GVHD Drugs 62 2002 879 889
34. A. Nagler, Y. Menachem, and Y. Ilan Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment J Hematother Stem Cell Res 10 2001 411 417
35. F. Carnevale-Schianca, P. Martin, and K. Sullivan Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease Biol Blood Marrow Transplant 6 2000 613 620
36. B. Kahan Sirolimus: a comprehensive review Expert Opin Pharmacother 2 2001 1903 1917
37. C.G. Groth, L. Backman, and J.M. Morales Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group Transplantation 67 7 1999 1036 1042
38. L. Johnston, J. Brown, and J.A. Shizuru Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease Biol Blood Marrow Transplant 11 2005 47 55
39. J. Lipsky Mycophenolate mofetil Lancet 348 1996 1357 1359
40. N. Basara, W.I. Blau, and E. Römer Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients Bone Marrow Transplant 22 1998 61 65
41. A. Busca, F. Locatelli, F. Marmont, E. Audisio, and M. Falda Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease Haematologica 88 2003 837 839
42. M. Fimiani, M. Di Renzo, and P. Rubegni Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease Brit J Dermatol 150 2004 1055 1060
43. R. Dall'Amico, and C. Messina Extracorporeal photochemotherapy for the treatment of graft-versus-host disease Ther Apher 6 2002 296 304
44. K. Schultz, and A.L. Gilman The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease Leuk Lymphoma 24 1997 201 210
45. A. Gilman, K.W. Chan, and A. Mogul Hydroxychloroquine for the treatment of chronic graft-versus-host disease Biol Blood Marrow Transplant 6 2000 327 334
46. D. Gaziev, and G. Lucarelli Novel approaches to the treatment of chronic graft-versus-host disease Expert Opin Investig Drugs 10 2001 909 923
47. S. Lee, S.A. Wegner, C.J. McGarigle, B.E. Bierer, and J.H. Antin Treatment of chronic graft-versus-host disease with clofazimine Blood 89 1997 2298 2302
48. P. Wood, and S.J. Proctor The potential use of thalidomide in the therapy of graft-versus-host disease - a review of clinical and laboratory information Leuk Res 14 1990 395 399
49. R. Barnhill, and A.C. McDougall Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions J Am Acad Dermatol 7 1982 317 323
50. P. Parker, N. Chao, and A. Nademanee Thalidomide as salvage therapy for chronic graft-versus-host disease Blood 86 1995 3604 3609
51. M. Higman, G.B. Vogelsang, and A. Chen Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease Expert Opin Pharmacother 5 2004 2605 2613
52. J. Goldberg, D.A. Jacobsohn, and J. Margolis Pentostatin for the treatment of chronic graft-versus-host disease in children J Pediatr Hematol Oncol 25 2003 584 588
53. E.S. Chan, and B.N. Cronstein Molecular action of methotrexate in inflammatory diseases Arthritis Res 4 4 2002 266 273
54. R. Storb, W. Leisenring, and C. Anasetti Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine? Biol Blood Marrow Transplant 3 4 1997 194 201
55. A.T. Borchers, C.L. Keen, G.S. Cheema, and M.E. Gershwin The use of methotrexate in rheumatoid arthritis Semin Arthritis Rheum 34 1 2004 465 483
56. L. Giaccone, P. Martin, and P. Carpenter Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease Bone Marrow Transplant 36 2005 337 341
57. X.J. Huang, Q. Jiang, and H. Chen Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 36 2005 343 348
58. K.Y. Chiang, S. Abhyankar, K. Bridges, K. Godder, and J.P. Henslee-Downey Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease Transplantation 73 4 2002 665 667
59. W. Willenbacher, N. Basara, I.W. Blau, A.A. Fauser, and M.G. Kiehl Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab Brit J Haematol 112 2001 820 823
60. V. Ratanatharathorn, L. Ayash, and C. Reynolds Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody Biol Blood Marrow Transplant 9 2003 505 511
61. M.R. Canninga-van Dijk, H.M. van der Straaten, R. Fijnheer, C.J. Sanders, J.G. van den Tweel, and L.F. Verdonck Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease Blood 104 8 2004 2603 2606
62. G. Summerfield, A.J. Bellingham, C. Bunch, and J.C. Woodrow Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine Clin Lab Haematol 5 1983 313 318
63. D.C. Marcellus, V.L. Altomonte, and E.R. Farmer Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease Blood 93 1 1999 66 70
64. S. Elad, R. Or, A.A. Garfunkel, and M.Y. Shapira Budesonide: a novel treatment for oral chronic graft versus host disease Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 2003 308 311
65. D. Wolff, V. Anders, R. Corio, T. Horn, W.L. Morison, and E. Farmer Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease Photodermatol Photoimmunol Photomed 20 2004 184 190
66. C. Feliciani, and A. Tulli Topical cyclosporin in the treatment of dermatologic diseases Int J Immunopathol Pharmacol 15 2002 89 93
67. D. Eisen, C.N. Ellis, E.A. Duell, C.E. Griffiths, and J.J. Voorhees Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis N Engl J Med 323 1990 290 294
68. J. Epstein, and D.E. Reece Topical cyclosporin A for treatment of oral chronic graft-versus-host disease Bone Marrow Transplant 13 1994 81 86
69. J. Epstein, and E.L. Truelove Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82 1996 532 536
70. E. Yoo, A.H. Rook, R. Elenitsas, F.P. Gasparro, and B.R. Vowels Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action J Investig Dermatol 107 1996 235 242
71. K. Atkinson, P. Weller, W. Ryman, and J. Biggs PUVA therapy for drug-resistant graft-versus-host disease Bone Marrow Transplant 1 1986 227 236
72. S. Elad, A.A. Garfunkel, C.D. Enk, D. Galili, and R. Or Ultraviolet B irradiation: a new therapeutic concept for the management of oral manifestations of graft-versus-host disease Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 1999 444 450
73. S. Elad, R. Or, and M.Y. Shapira CO2 laser in oral graft-versus-host disease: a pilot study Bone Marrow Transplant 32 2003 1031 1034
74. A. Anstey, S. Wakelin, and N.J. Reynolds Guidelines for prescribing azathioprine in dermatology Brit J Dermatol 151 2004 1123 1132
75. J. Epstein, S. Nantel, and S.M. Sheoltch Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease Bone Marrow Transplant 25 2000 683 687
76. C. Choi, and P. Nghiem Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients Arch Dermatol 137 2001 1202 1206
77. N. Reynolds, and W.I. Al-Daraji Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology Clin Exp Dermatol 27 2002 555 561
78. J. Byrd, M.D. Davis, A.J. Bruce, L.A. Drage, and R.S. Rogers Response of oral lichen planus to topical tacrolimus in 37 patients Arch Dermatol 140 2004 1508 1512
79. A. Eckardt, O. Starke, M. Stadler, C. Reuter, and B. Hertenstein Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus Oral Oncol 40 2004 811 814
80. R.E. Curtis, C. Metayer, and J.D. Rizzo Impact of chronic GvHD therapy on the development of squamous cell cancers after hematopoietic stem cell transplantation: an international case-control study Blood 105 10 2005 3802 3811